Francois Vigneault
Francois Vigneault is currently the founder of Enigma Bio, Pi Bio, and Reflexion Bio. He previously founded AbVitro Inc. and has expertise in biotech, AI, and genomic medicine, focusing on leveraging large-scale biological data and machine learning for breakthroughs in molecular biology.
Recent coverage
Front-page news, podcasts and videos about Francois
Flexe hires Amazon biometrics lead Lara Rogers as SVP/GM; Magnify names ex‑Amazon Sajo Jacob CTO; Schuster joins Open Systems board
Several Seattle-area tech companies announced senior hires and board moves: Flexe hired former Amazon biometrics leader Lara Rogers as SVP and GM; Magnify named Sajo Jacob as CTO and co‑founder after a $6M launch; Open Systems added ex‑Microsoft exec Gavriella Schuster to its board; Fabric and Scener also announced senior appointments.
Shape Therapeutics raises $112M to advance RNA-editing platform and AAV gene-delivery for neurological and genetic diseases
Seattle preclinical biotech Shape Therapeutics raised $112 million to develop RNA-editing and gene therapy technologies, including improved AAV delivery vectors and an RNA editing platform. The company, led by CEO and co-founder Francois Vigneault and leveraging work from co-founder Prashant Mali, aims to target neurological and genetic diseases such as Parkinson's, Alzheimer’s, alpha-1 antitrypsin deficiency, and Rett syndrome.
Organizations
See all 9-
Enigma Bio Founder 2025–present · current
-
Pi Bio Founder 2025–present · current
-
Reflexion Bio Founder 2025–present · current
Education
-
Université Laval PhD, Molecular and Cellular Biology · 2004–2007
-
Université Laval M.Sc, Molecular and Cellular Biology · 2002–2004
-
Université Laval BSc, Microbiology · 1999–2002
